Attached files

file filename
EX-99.1 - NutriBand Inc.ex99.htm

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549 

 

 FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) May 10, 2018

 

 

 

Nutriband, INC.

 

Nevada 000-55654 81-1118176

(State or Other Jurisdiction

 of Incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

 

309 Celtic Ct., Oviedo Florida  

 32765
(Address of Principal Executive Offices) (Zip Code)

 

(800) 377-2137

Registrant’s Telephone Number, Including Area Code

 
 
 
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

|_|Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|_|Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|_|Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|_|Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Type: 8-K

Comme

 
 

nt/Description:

 Item 2.02 Results of Operations and Financial Condition

 

On May 10, 2018, The Company has issued a Press Release announcing that it has signed an exclusive 20-year, $90 million distribution agreement for its transdermal consumer product lines with Best Choice Inc.

 

FOR THE FULL TERMS OF THE Press Release, PLEASE REFER TO THE COPY THEREOF FILED AS EXHIBIT 99.2 TO THIS REPORT.

 

The company issued a Press Release on May10, 2018.

  

Item 8.01 Other Events.

 

DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS

 

Throughout this report, we make statements that may be deemed "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, that address activities, events, outcomes and other matters that Chancellor plans, expects, intends, assumes, believes, budgets, predicts, forecasts, projects, estimates or anticipates (and other similar expressions) will, should or may occur in the future are forward-looking statements. These forward-looking statements are based on management's current belief, based on currently available information, as to the outcome and timing of future events. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements in this report.

 

 Any forward-looking statements that we may make are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those anticipated by us. Any forward-looking statements are subject to the risks and uncertainties that could cause actual results of operations, financial condition, cost reductions, acquisitions, dispositions, financing transactions, operations, expansion, consolidation and other events to differ materially from those expressed or implied in such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements. As a result, the reader is cautioned not to rely on these forward-looking statements. Due to known and unknown risks, the company’s actual results may differ materially from its expectations or projections.

    

While most risks affect only future costs or revenues anticipated by the company, some risks may relate to accruals that have already been reflected in results of operations. The company’s failure to receive payments of accrued amounts or if liabilities are incurred in excess of amounts previously recognized, a charge against future earnings could result. In addition, any forward-looking statements should be considered in context with various disclosures made by us about our business including, without limitation, the risk factors more particularly described below in “Risk Factors.”

 

 
 

Item 9.01. Financial Statements and Exhibits.

(c) Exhibits.

Exhibit Number Description 
99.1

Press release issued by Nutriband, Inc. May 10, 2018

 

 

 
 

 

SIGNATURES

 

PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.

 

     
 

 

 

 

Nutriband, INC.

     
Date: May 15, 2018 By:   /s/ Gareth Sheridan
  R: Gareth Sheridan
  Chief Executive Officer